Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction

Citer cette référence
ROCCA, Carmine, DE BARTOLO, Anna, GRANDE, Fedora, RIZZUTI, Bruno, PASQUA, Teresa, GIORDANO, Francesca, GRANIERI, Maria Concetta, OCCHIUZZI, Maria Antonietta, GAROFALO, Antonio, AMODIO, Nicola, CERRA, Maria Carmela, SCHNEIDER, Francis, PANNO, Maria Luisa, METZ-BOUTIGUE, Marie-Hélène et ANGELONE, Tommaso, 2021. Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction. International Immunopharmacology. mai 2021. Vol. 94, pp. 107487. DOI 10.1016/j.intimp.2021.107487.